The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Medicine, Cardiology, Pharmacology +12

Triglycerides and Cardiovascular Disease

Michael Miller, Neil J. Stone, Christie M. Ballantyne et al. · Circulation · 2011 · 1.9K citations · Full text

Life Sciences, Cardiology, Nutritional Sciences +12

Loss-of-Function Mutations in <i>APOC3</i> and Risk of Ischemic Vascular Disease

Anders Berg Jørgensen, Ruth Frikke‐Schmidt, Børge G. Nordestgaard et al. · New England Journal of Medicine · 2014 · 915 citations · Full text

Medicine, Genetics, Molecular Genetics +12

AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update

Sidney C. Smith, Steven N. Blair, Robert O. Bonow et al. · Journal of the American College of Cardiology · 2001 · 692 citations

Medicine, Cardiology, Clinical Cardiology +10

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease

Enyu Imai, Masaru Horio, Kosaku Nitta et al. · Clinical and Experimental Nephrology · 2007 · 542 citations

Pharmacy, Nephrology, Hemodialysis +14